Researchers found that SARS-CoV-2 had spread throughout the body via the blood vessels, infecting various types of cell and tissue in these children. The clinical manifestations varied according to the organ targeted.
New tool uses AI technology to assess the severity of lung infections and inform treatment
Artificial intelligence (AI) technology developed by researchers at the University of Waterloo is capable of assessing the severity of COVID-19 cases with a promising degree of accuracy.
Key lesson from the coronavirus pandemic is the need for partnership between academic excellence, industry and public health organisations. Centre will unite disciplines, and sectors, to build agile, equitable partnerships that can tackle complex problems and respond to pandemic threats at any time. Centre will build on the UK and international reach of Oxford s research collaborations.
The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute s Center for Infectious Disease and Vaccine Research.
A study coordinated by Luís Graça, principal investigator at the Instituto de Medicina Molecular (iMM; Portugal) used lymph nodes, tonsils and blood, to show how the cells that control production of antibodies are formed and act. The results published now in the scientific journal Science Immunology unveiled key aspects about the regulation of antibody production, with significant importance for diseases where antibody production is dysregulated such as autoimmune diseases or allergies.